4//SEC Filing
Kirschbaum Mark 4
Accession 0001104659-20-118939
CIK 0001130166other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:12 PM ET
Size
5.5 KB
Accession
0001104659-20-118939
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-10-23+120,000→ 120,000 totalExercise: $3.77Exp: 2030-10-23→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 40,000 shares on October 23, 2021, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001830211
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:12 PM ET
- Size
- 5.5 KB